1. 1. Ishizuka M, Abe F, Sano Y, Takahashi K, Inoue K, Nakajima M, Kohda T, Komatsu N, Ogura S & Tanaka T (2011): Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy. Int Immunopharmacol 11: 358−365
2. 2. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F & Reulen HJ; ALA-Glioma Study Group (2006): Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial. Lancet Oncol 7: 392−401
3. 3. Yamamoto J, Takahashi M, Idei M et al (2012): A pitfall of fluorescence-guided surgery with 5-aminolevluinic acid for the treatment of malignant brain tumor -case report-. ALA-Porphyr Sci 1: 61−66
4. 4. Kaneko S (2008): A current overview: Photodynamic diagnosis and photodynamic therapy using 5-aminolevulinic acid in neurosurgery. Nippon Laser Igakkaishi 29: 135−146
5. 5. Stummer W, Novotny A, Stepp H, Goetz C, Bise K & Reulen HJ (2000): Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: A prospective study in 52 consecutive patients. J Neurosurg 93: 1003−1013